A near-infrared fluorescent molecular probe for detecting cysteine ​​and a preparation method and a kit thereof

By designing the near-infrared fluorescent molecular probe DBCM-Cys, the ICT system is used to achieve high sensitivity and specific detection of cysteine, which solves the lack of wavelength detection of cysteine ​​in living cells in the prior art and cell penetration. The problem of poor ability achieves low-cost and high-sensitivity detection effect.

CN116375692BActive Publication Date: 2024-11-08HUNAN TARGETING DETECTION TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310407375.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-17
Publication Date
2024-11-08
Estimated Expiration
2043-04-17

AI Technical Summary

Technical Problem

The existing methods for detecting cysteine ​​are not suitable in living cells, and the wavelength of fluorescent molecular probes is not long enough, resulting in poor cell penetration ability and large background interference, making it difficult to achieve high sensitivity and specific detection.

Method used

A near-infrared fluorescent molecular probe DBCM-Cys was designed to generate the dark red solid product DBCM through the reaction of DCM and HBC, and react with triethylamine and acryloyl chloride in anhydrous dichloromethane to form a maximum emission wavelength of 714 nm. The fluorescent probe combines with the ICT system to achieve specific detection of cysteine.

Benefits of technology

Achieve low-cost and simple two-step synthesis, with high sensitivity and specificity, excellent anti-interference ability for cysteine ​​detection, and is suitable for the detection of endogenous and exogenous cysteine ​​in living cells. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116375692B_ABST
    Figure CN116375692B_ABST
Patent Text Reader

Abstract

A near-infrared fluorescent molecular probe DBCM‑Cys for detecting cysteine ​​has the following structural formula: #imgabs0# The near-infrared fluorescent molecular probe described in the present invention can be synthesized in only two steps and is simple to operate. After reacting with cysteine, the fluorescence intensity at 714nm will be significantly enhanced. The fluorescence emission band is in the near-infrared light region, with little background interference, high accuracy and sensitivity, and excellent specificity, and is not interfered by other common amino acids and inorganic salt ions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a near-infrared fluorescent molecular probe for detecting cysteine ​​and a preparation method and a kit thereof, belonging to the technical field of organic small molecule fluorescent probes. Background Art

[0002] Cysteine ​​(Cys) is an important small molecule biothiol that is widely present in biological systems and is associated with a variety of physiological and pathological activities. Studies have shown that Cys plays a key role in maintaining the homeostasis of redox balance. Therefore, abnormal levels of Cys can lead to the occurrence of a variety of diseases. For example, a lack of Cys can lead to slow growth and liver damage, while excessive Cys content can lead to neuropathies such as Alzheimer's disease. Therefore, it is of great significance to detect cysteine ​​in biological systems. So far, UV-visible absorption spectrophotometry, high-performance liquid chromatography, and high-performance liquid chromatography tandem mass spectrometry (HPLC-MS) have been developed for the detection of Cys. However, since the intracellular environment of living cells is very complex, and these methods usually require special instruments and equipment, and destroy and post-mortem treatment of tissues or cells, they are not suitable for the detection of Cys in living systems such as living cells. In contrast, fluorescent molecular probes have high sensitivity, strong specificity, good biocompatibility, and can achieve real-time non-invasive detection, and have also been used for the detection of Cys.

[0003] For example, the invention patent application with application number CN201710282924.9 and titled “A fluorescent probe for detecting cysteine, its preparation method and application” uses naphthaleneimide dye as raw material to design and synthesize naphthaleneimide-acrylate fluorescent probe, which can emit fluorescence at 669nm when reacting with cysteine.

[0004] For example, the invention patent application with application number CN201710053670.3 and title “A fluorescent probe for identifying cysteine ​​and homocysteine ​​with naphthalimide as the parent core, and its preparation and application” uses naphthalimide as the parent core to prepare a fluorescent probe for identifying cysteine ​​and homocysteine, with an excitation wavelength of 488nm and an emission wavelength of 520nm to 610nm.

[0005] The above documents are all fluorescent probes for detecting Cys prepared with naphthalene imide as raw material, but their wavelengths are not long enough. Near-infrared fluorescent molecular probes (maximum emission wavelength is 700-900nm) have better cell penetration ability, less tissue damage, lower background interference and lower cytotoxicity, and are more suitable for the detection of Cys in living systems such as cells. Therefore, it is very important and meaningful to develop a near-infrared fluorescent probe that can detect cysteine. Summary of the invention

[0006] In view of the above problems, the present invention proposes a near-infrared fluorescent molecular probe for detecting cysteine, a preparation method thereof and a kit. The fluorescent molecular probe can specifically detect cysteine ​​and has strong anti-interference ability.

[0007] The technical means adopted by the present invention to solve the above problems are: a near-infrared fluorescent molecular probe DBCM-Cys for detecting cysteine, the structural formula of which is as follows:

[0008]

[0009] A method for preparing a near-infrared fluorescent molecular probe for detecting cysteine, comprising the following steps:

[0010] (1) DCM and HBC are fully dissolved in acetonitrile solvent, piperidine is added, and the reaction is refluxed at 40-60° C. under the protection of an inert gas such as nitrogen or argon until completion, the reaction solvent is removed under reduced pressure, and a dark red solid product DBCM is obtained by column chromatography purification; wherein the ratio of DCM to HBC is 1:0.8-1:1.5 mmol / mmol, the ratio of DCM to solvent is 1:8-1:15 mmol / mL, and the ratio of DCM to piperidine is 12:1-7:1 mmol / mmol;

[0011] (2) Under inert gas protection at 0°C, DBCM is dissolved in anhydrous dichloromethane, triethylamine is added dropwise, and finally a dichloromethane solution containing acryloyl chloride is slowly added dropwise, and the reaction is stirred at 0°C until the reaction is complete. The organic layers are extracted and combined, dried and concentrated, and purified by column chromatography to obtain the target fluorescent probe DBCM-Cys; wherein the dosage ratio of DBCM to anhydrous dichloromethane is 1:8-1:20 mmol / mL, the dosage ratio of DBCM to triethylamine is 1.5:1-2.5:1 mmol / mL, the concentration of the dichloromethane solution of acryloyl chloride is 1:4-1:6 mmol / mL, and the dosage ratio of DBCM to acryloyl chloride is 1:1-1:1.5 mmol / mmol.

[0012] The synthetic route is as follows:

[0013]

[0014] A kit for detecting cysteine ​​comprises a reagent stock solution a and a reagent stock solution b, wherein the reagent stock solution a is an acetonitrile-PBS buffer solution, and the reagent stock solution b is an organic solvent solution of a DBCM-Cys fluorescent molecular probe, wherein the organic solvent is selected from one of dimethyl sulfoxide, N,N-dimethylformamide and acetonitrile.

[0015] Furthermore, the volume ratio of acetonitrile to PBS buffer solution in the reagent stock solution a is 3:7, and the pH is 7.4; the concentration of the fluorescent molecular probe in the reagent stock solution b is 1 mM.

[0016] Furthermore, the volume ratio of the reagent stock solution a and the reagent stock solution b in the kit is 99 / 1.

[0017] The detection principle of the Cys detection kit of the present invention is:

[0018] An intramolecular charge transfer (ICT) system was constructed using DCM and naphthaleneimide fluorophore. Since acrylate inhibited the ICT effect of the probe itself, no fluorescence emission was observed. However, when Cys was present, the acrylate bond was broken and replaced by a hydroxyl group, which eliminated its inhibitory effect and caused the probe molecule to emit strong fluorescence. Through the above scheme, an "on-off" type fluorescence response was obtained, achieving highly sensitive and specific detection of Cys. The detection mechanism is as follows:

[0019]

[0020] The beneficial effects of the present invention are:

[0021] 1. The near-infrared fluorescent molecular probe described in the present invention can be synthesized in only two steps, with low cost and easy operation.

[0022] 2. The near-infrared fluorescent molecular probe described in the present invention can achieve specific detection and high-sensitivity recognition of Cys, and Hcy and GSH with similar structures will not interfere with it.

[0023] 3. The near-infrared fluorescent molecular probe described in the present invention has a maximum emission wavelength of 714 nm, which is in the near-infrared region and is conducive to the detection of endogenous and exogenous Cys in living cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 The emission spectrum of the fluorescence intensity of the fluorescent probe of Example 2 as it changes with the Cys concentration;

[0025] Figure 2 is a linear relationship diagram between the fluorescence intensity and Cys concentration of the fluorescent probe in Example 2;

[0026] Figure 3 This is the selectivity diagram of the fluorescent probe for Cys in Example 3;

[0027] Figure 4 These are fluorescence confocal images of the fluorescent probe in Example 4 in HeLa cells, where a is an image of the cells treated with the probe for 30 minutes; b is an image of the cells treated with NEM first and then with the probe for 30 minutes. DETAILED DESCRIPTION

[0028] The present invention is further described below in conjunction with the accompanying drawings.

[0029] Embodiment 1

[0030] Synthesis of compound DBCM

[0031] Take a 50mL round-bottom flask, add DCM (2-(2-methyl-4H-benzopyran-4-ylidene) propanonitrile) (416.44mg, 2mmol) and HBC (2-butyl-6-hydroxy-1,3-dioxo-2,3-dihydro-1H-benzo[d]isoquinoline-5-carbaldehyde) (594.62mg, 2mmol), and add acetonitrile 20mL to fully dissolve it. Then, piperidine (0.2mmol) is added dropwise to the reaction system, and the reaction system is placed at 50°C for reflux reaction under nitrogen protection. TLC monitors the reaction progress until the reaction is completed, removes the reaction solvent under reduced pressure, and purifies by column chromatography to obtain a dark red solid product DBCM805.37 mg, with a yield of 82.6%. 1 H NMR (400MHz, CDCl3) δ9.04(s,1H),8.51(d,J=7.8Hz,1H),8.41(d,J=7.9Hz,1H),7.80(t,J=7.8Hz,1H),7.36-7.31(m,2H),7.17(d,J=7.4H z,1H),7.03-6.98(m,2H),6.63-6.57(m,2H),5.66(s,1H),3.16-3.13(m,2H),1.79-1.69(m,2H),1.54-1.47(m,2H),0.90(t,J=7.2Hz,3H).

[0032] Synthesis of compound DBCM-Cys

[0033] Take a 25mL round-bottom flask, add DBCM (487.52mg, 1mmol) at 0℃ under nitrogen protection, add 10mL of anhydrous dichloromethane to fully dissolve it, add triethylamine (0.5mL) to the reaction system, and finally slowly drop 5mL of dichloromethane solution containing acryloyl chloride (90.5mg, 1mmol). Stir overnight at 0℃. Extract with water, saturated NaHCO3 solution and saturated NaCl solution respectively, combine the organic layers, dry with anhydrous magnesium sulfate and concentrate, and purify by column chromatography to obtain the target fluorescent probe DBCM-Cys385.59 mg with a yield of 71.2%. 1H NMR (400MHz, CDCl3) δ8.51(d,J=7.6Hz,1H),8.41(d,J=8.0Hz,1H),7.80(t,J=7.4 Hz,1H),7.37-7.30(m,2H),7.17-7.10(m,2H),6.93(t,J=7.8Hz,1H),6.63(d,J=13 .8Hz,1H),6.51(s,1H),6.24-6.18(m,2H),5.74(d,J=6.4Hz,1H),5.66(s,1H),3.1 8-3.13(m,2H),1.52-1.45(m,4H),0.88(t,J=7.2Hz,3H).HRMS-ESI(m / z)calc.for C 33 H 23 N3O5:541.16377; found, [M+H] + 542.03491.

[0034] Embodiment 2

[0035] This example shows the change of fluorescence intensity of fluorescent probe and Cys concentration

[0036] Take 4.82 mg of the fluorescent probe prepared in Example 1, carefully transfer it to a 10 mL volumetric flask, add DMSO at room temperature, shake well to completely dissolve it, and finally adjust the volume to the scale line to obtain a 1 mM probe mother solution. Take 20 μL of it, dissolve it in 588 μL of acetonitrile and 1372 μL of PBS buffer solution respectively, and add 20 μL of Cys mother solution of different concentrations thereto, and ensure that the total volume of each test is 2 mL, so that the concentration of the fluorescent probe in the test system is 10 μM, and the concentration of Cys is 0 μM, 0.5 μM, 1 μM, 2 μM, 5 μM, 10 μM, 15 μM, 20 μM, 30 μM, 50 μM. After incubating at room temperature for 20 minutes for full response, test the fluorescence spectra of different systems in a 10 mm cuvette. See the change in fluorescence emission spectrum. Figure 1 The results show that with the increase of Cys concentration, the fluorescence intensity of the system at 714nm gradually increases. Figure 2 It can be concluded that there is a good linear relationship in the range of 0-10 μM, the linear equation is y=16.76817x+11.73542, the linear correlation coefficient is: 0.97492, and the detection limit (LOD) is calculated to be 0.17 μM (S / N=3), indicating that the fluorescent probe has good sensitivity.

[0037] Embodiment 3

[0038] This example shows the selectivity of the fluorescent probe in response to Cys.

[0039] Take 20 μL of 1 mM probe stock solution and dissolve it in 588 μL of acetonitrile and 1372 μL of PBS buffer solution respectively. Then take 20 μL of 1 mM Cys stock solution and 3 mM GSH, Hcy, Met, Leu, Ala, Phe, Trp, Tys, Glu, NaHS, and Na2S stock solutions and add them into the detection system respectively. Finally, the concentration of the probe in the whole detection system is 10 μM, the concentration of Cys is 10 μM, and the concentration of GSH, Hcy, Met, Leu, Ala, Phe, Trp, Tys, Glu, NaHS, and Na2S are 10 μM. - , S 2- The concentration was 30 μM. After incubation at room temperature for 20 min to fully respond, the fluorescence spectra of different systems were tested in a 10 mm cuvette, and the relative fluorescence intensity value at 714 nm was calculated. The corresponding fluorescence intensity at 714 nm was used as the ordinate to obtain a bar graph of the probe's response to different substances. The results are shown in Figure 2. Figure 3 The results show that the probe has excellent anti-interference in response to Cys and will not be affected by other amino acids and analogs.

[0040] Embodiment 4

[0041] Investigation of the response of probes to Cys in living cells

[0042] 10% fetal bovine serum and penicillin (100 units / mL)-streptomycin (100 μg / mL) solution were added to the DMEM medium, and the HeLa cells were cultured in the medium at 37°C and 5% CO2. After 12 hours, the cell culture medium was removed from the wells and the cells were washed three times with D-Hanks. The HeLa cells were then incubated with 20 μM DBCM-Cys and DMEM culture medium containing 10% fetal bovine serum at 37°C for 30 minutes, then washed twice with PBS and mounted on a microscope stage to observe the fluorescence changes. Obvious fluorescence ( Figure 4 However, if HeLa cells were pre-treated with N-ethylmaleimide (a widely used thiol blocking agent) and then incubated with the probe for 30 minutes, almost no red fluorescence was observed ( Figure 4 (b) This indicates that DBCM-Cys can be used as a NIR fluorescent molecular probe for imaging Cys in living cells.

[0043] The above embodiments are only used to illustrate the present invention, rather than to limit the present invention. Technicians in the relevant technical field may make various changes or modifications without departing from the spirit and scope of the present invention. Therefore, all equivalent technical solutions should also fall within the protection scope of the present invention, and the protection scope of the present invention should be defined by the claims.

Claims

1. A near-infrared fluorescent molecular probe DBCM-Cys for detecting cysteine, characterized in that: The structural formula is as follows:

2. A method for preparing a near-infrared fluorescent molecular probe for detecting cysteine, characterized in that: Here are the steps: (1) DCM and HBC were fully dissolved in acetonitrile solvent, piperidine was added, and the reaction was refluxed at 40-60°C under inert gas protection until completion, and DBCM was purified; (2) Under inert gas protection, 0 o Dissolve DBCM in anhydrous dichloromethane at 0 °C, add triethylamine dropwise, and finally slowly drop into a dichloromethane solution containing acryloyl chloride. o C and stirred until the reaction is complete, and the target fluorescent probe DBCM-Cys can be obtained after purification.

3. The method for preparing a near-infrared fluorescent molecular probe for detecting cysteine ​​according to claim 2, characterized in that: The inert gas is nitrogen or argon.

4. The method for preparing a near-infrared fluorescent molecular probe for detecting cysteine ​​according to claim 2, characterized in that: In step (1), the reflux temperature is 50°C.

5. The method for preparing a near-infrared fluorescent molecular probe for detecting cysteine ​​according to claim 2, characterized in that: In step (1), the ratio of DCM to HBC is 1:0.8 to 1:1.5 mmol / mmol, the ratio of DCM to solvent is 1:8 to 1:15 mmol / mL, and the ratio of DCM to piperidine is 12:1 to 7:1 mmol / mmol; In step (2), the dosage ratio of DBCM to anhydrous dichloromethane is 1:8~1:20 mmol / mL, the dosage ratio of DBCM to triethylamine is 1.5:1~2.5:1 mmol / mL, the concentration of dichloromethane solution of acryloyl chloride is 1:4~1:6 mmol / mL, and the dosage ratio of DBCM to acryloyl chloride is 1:1~1:1.5 mmol / mmol.

6. The method for preparing a near-infrared fluorescent molecular probe for detecting cysteine ​​according to claim 2, characterized in that: In step (1), the ratio of DCM to HBC is 1:1 mmol / mmol, the ratio of DCM to solvent is 1:10 mmol / mL, and the ratio of DCM to piperidine is 10:1 mmol / mmol; In step (2), the usage ratio of DBCM to anhydrous dichloromethane is 1:10 mmol / mL, the usage ratio of DBCM to triethylamine is 2:1 mmol / mL, the concentration of dichloromethane solution of acryloyl chloride is 1:5 mmol / mL, and the usage ratio of DBCM to acryloyl chloride is 1:1 mmol / mmol.

7. The method for preparing a near-infrared fluorescent molecular probe for detecting cysteine ​​according to claim 2, characterized in that: In step (1), the purification method is to remove the solvent under reduced pressure and purify by column chromatography; in step (2), the purification method is to extract, combine the organic layers, dry and concentrate, and purify by column chromatography.

8. A kit for detecting cysteine, comprising a reagent stock solution a and a reagent stock solution b, characterized in that: The reagent stock solution a is an acetonitrile-PBS buffer solution, and the reagent stock solution b is an organic solvent solution of the DBCM-Cys fluorescent molecular probe, wherein the organic solvent is selected from one of dimethyl sulfoxide, N,N-dimethylformamide, and acetonitrile; wherein the DBCM-Cys structural formula is as follows:

9. The kit for detecting cysteine ​​according to claim 8, characterized in that: The volume ratio of acetonitrile and PBS buffer solution in the reagent stock solution a is 3:7, pH=7.4; the concentration of the fluorescent molecular probe in the reagent stock solution b is 1 mM.

10. The kit for detecting cysteine ​​according to claim 8, characterized in that: The volume ratio of the reagent stock solution a and the reagent stock solution b in the kit is 99 / 1.